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Environmental chronic stress (ECS) has been identiﬁed as a trigger of acute coronary syndromes (ACS). Changes in redox balance,
enhanced reactive oxygen species (ROS) production, and platelet hyperreactivity were detected in both ECS and ACS. However, the
mechanisms by which ECS predisposes to thrombosis are not fully understood. Here, we investigated the impact of ECS on platelet
activation and megakaryopoiesis in mice and the eﬀect of Apocynin in this experimental setting. ECS induced by 4 days of forced
swimming stress (FSS) treatment predisposed to arterial thrombosis and increased oxidative stress (e.g., plasma malondialdehyde
levels). Interestingly, Apocynin treatment prevented these alterations. In addition, FSS induced abnormal megakaryopoiesis
increasing the number and the maturation state of bone marrow megakaryocytes (MKs) and aﬀecting circulating platelets. In
particular, a higher number of large and reticulated platelets with marked functional activation were detected after FSS.
Apocynin decreased the total MK number and prevented their ability to generate ROS without aﬀecting the percentage of
CD42d+ cells, and it reduced the platelet hyperactivation in stressed mice. In conclusion, Apocynin restores the physiological
megakaryopoiesis and platelet behavior, preventing the detrimental eﬀect of chronic stress on thrombosis, suggesting its
potential use in the occurrence of thrombosis associated with ECS.
1. Introduction
Thrombosis is a pathological event, which can aﬀect both
veins and arteries, whose clinical manifestation is associ-
ated with deep vein thrombosis, myocardial infarction,
cerebral stroke, and pulmonary embolism. A number of
studies have shown a strong link between cardiovascular
disease and psychological stress. Thus, psychological stress
has been recently included as risk factor for cardiovascular
disease [1–3]. In particular, psychological/environmental
stress, inducing hyperactivation of platelets and coagulation
factors and modifying the normal ﬁbrinolytic processes,
triggers a hypercoagulable state [4], predisposing to car-
diovascular disease.
Interestingly, modiﬁcations in the redox balance and in
the reactive oxygen species (ROS) production and alter-
ations of genes regulating antioxidant systems, including
NADPH oxidase, occur in both chronic stress and cardio-
vascular disease [5–9].
Several studies showed that endothelial cells, leukocytes,
vascular smooth muscle cells, ﬁbroblasts, and platelets are
important sources of ROS after vascular injury and that these
ROS can regulate platelet activation [10, 11], triggering a
vicious circle that leads to thrombosis. However, the mecha-
nisms by which chronic environmental stress predisposes to
thrombosis and thereby to cardiovascular disease are not
fully understood.
Therapeutic approaches targeting ROS production to
reduce atherothrombotic risk and to prevent neurodegenera-
tive diseases are developing [12–14]. One of the most prom-
ising antioxidant drugs in experimental models is Apocynin
(4-hydroxy-3-methoxyacetophenone) [15]. Apocynin is an
active principle with anti-inﬂammatory properties [16] iso-
lated from the root of the medicinal plant Picrorhiza Kurroa
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(Scrophulariaceae) [17]. Apocynin aﬀects ROS generation
inhibiting NADPH oxidase enzyme activation, and it turns
out to be a scavenger of hydrogen peroxide [15, 18].
In this study, we aimed at evaluating the beneﬁcial
eﬀect(s), if any, of Apocynin in preventing thrombosis
induced by chronic psychological/behavioral stress and at
exploring the underlying mechanism(s).
2. Methods
2.1. Ethics Statement and Experimental Design. The experi-
mental groups consisted of FVB male mice (12–14 weeks
old) supplied by Charles River and housed in a tempera-
ture-controlled, 12 h light/dark cycle environment with ad
libitum access to water and fed on standard pellet diet. All
experiments were approved by the National Ministry of
Health-University of Milan Committee and of DGSA. Surgi-
cal procedures were performed in mice anesthetized with
ketamine chlorhydrate (75mg/kg; Intervet) and medetomi-
dine (1mg/kg; Virbac). Mice were randomized in diﬀerent
groups. Apocynin (Sigma-Aldrich; 15mg/kg) or dimethyl-
sulfoxide (DMSO) was intraperitoneally (i.p.) injected 1 h
before start the ﬁrst session of stress [8] and then added to
the drinking water (300mg/kg) for 5 days [19], correspond-
ing to 2.4mg/ml since our mice approximately drink 3–
3.5ml water/day. No side eﬀects were reported during long
time treatment (2–16 weeks) with Apocynin [19, 20]. The
chronic forced swim stress (FSS) was performed as previ-
ously described [8]. Brieﬂy, mice were individually placed
in a 2000ml glass beaker (height, 24 cm; diameter, 12 cm)
ﬁlled with 1500ml of room temperature water for 5min
twice a day for 4 consecutive days. Mice were then quickly
dried with a towel and returned to their home cage. This
model of stress is based on the well-established ﬁnding
that repeated exposure to an inescapable stress, for which
no active coping responses are available, induces depres-
sive- and anxious-like behaviors in mice [21–23]. Interest-
ingly, this model of stress is considered a chronic model
because behavioral alterations are chronically maintained
for more than 4 weeks [24–26]. Experiments were per-
formed, and tissue, were collected 18h after the last sec-
tion of FSS (Figure 1).
Blood was collected into 3.8% sodium citrate (1 : 10 vol:-
vol) from anesthetized mice at time indicated. For plasma
preparation, citrated blood was centrifuged at 3000 rpm for
20min at 4°C to obtain plasma, which was immediately
stored at −80°C until further analysis.
2.2. Whole Blood Counts. Blood was collected into sodium
citrate from anesthetized mice by cardiac venipuncture, and
the diﬀerential white blood cell and platelet count were
performed on a Beckman Coulter AU480.
2.3. Rotational Thromboelastometry. Rotational Thromboe-
lastography (ROTEM®) was used to measure coagulability
in whole blood as previously described [27]. Brieﬂy, citrated
whole blood was added to a cuvette containing star-tem®
solution or ﬁb-tem® solution, and recording was started
immediately and was allowed to proceed for 60min accord-
ing to the manufacturer’s instructions. Clotting characteris-
tics were analysed in terms of clotting time (CT, time
necessary for the formation of a clot with a diameter of
2mm) and clot formation time (CFT, kinetic of a stable clot
formation by activated platelets and ﬁbrin) and maximum
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Figure 1: Design of the experiment: mice were randomized in 3 groups: control (vehicle), FSS (vehicle treatment and exposure to forced swim
stress for 5 minutes two times/day as indicated), and FSS plus Apocynin (Apocynin treatment and exposure to forced swim stress for
5 minutes two times/day as indicated) and then sacriﬁced as indicated in the Methods 18 hours after the last section of stress.
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clot ﬁrmness and maximum clot elasticity (MCF and MCE,
measure of the consistence and elasticity of the clot, resp.)
were collected.
2.4. Malondialdhyde and NADPH/NADP Analyses. Malon-
dialdhyde (Cat. MBS269473) and NADPH/NADP (Cat.
MBS169276) were measured in plasma and bone marrow,
respectively, by ELISA kit (MyBioSource) according the to
manufacturer’s instructions.
2.5. Arterial Thrombosis Model. Experimental arterial throm-
bosis was induced as previously described [28]. The left
carotid artery of anesthetized mice was dissected free and
placed in the probe (model 0.7V, Transonic System) con-
nected to transonic ﬂowmeter (Transonic T106). After blood
ﬂow stabilization (baseline ﬂow constant for 7min at least
0.8ml/sec), a 1× 1mm strip of ﬁlter paper (Whatman N°1)
soaked with FeCl3 (10% solution; Sigma-Aldrich) was
applied over the carotid artery. After 3min, the ﬁlter paper
was removed, the carotid artery was washed with PBS, and
the ﬂow was recorded for 30min. An occlusion was consid-
ered to be total and stable when the ﬂow was reduced by
>90% from baseline until the 30-minute observation time,
with the ﬂow during this period not changing by more than
1% from baseline per second.
2.6. Platelet–Leukocyte Aggregate Analysis. Platelet/monocyte
and platelet/neutrophil aggregates were analysed as previ-
ously described [29]. Brieﬂy, citrated blood was stimulated
where indicated with ADP for 5 minutes and red blood cells
were lysed by FACS Lysing solution (BD Biosciences);
samples were stained with the anti-CD45, anti-CD41, and
anti-CD14 or anti-Lys6G (eBiolegend, Cat. 103101, 133901,
150101, and 127601, resp.) and analysed by ﬂow FACS
“Novocyte 3000.” A minimum of 5000 events was collected
in the CD14+ or Lys6G+ gate.
2.7. Platelet Studies. Washed platelets (WPs) were obtained
from platelet-rich plasma (PRP), isolated following centrifu-
gation at 100g for 10min of citrated blood as previously
described [30], with serial centrifugation and addition of
0.2mM PGI2 and 0.01mg/l apyrase. Platelet pellets were
resuspended in HEPES-Tyrode’s buﬀer (137mM NaCl,
20mM HEPES, 5.6mM glucose, 0.35% bovine serum,
1mM MgCl2, 2.7mM KCl, and 3.3mM NaH2PO4).
25μl of WPs (5× 104/μl in HEPES-Tyrode’s buﬀer
supplemented with 1mM CaCl2) was mixed with a saturat-
ing concentration of PE-conjugated JON/A (Emfret Analytic,
Cat. M023-2) antibody, raised against the activated form
of GPIIbIIIa (αIIβΙII integrin), or with anti-CD62P and
FITC-conjugated antibody (P-selectin; BD Biosciences,
Cat. 553744), and the mixture reacted with diﬀerent con-
centrations of ADP or thrombin for 15 minutes at room
temperature. The reaction was stopped by 400μl ice-cold
PBS, and samples were analysed within 30minutes. Plate-
lets were identiﬁed by forward and side scatter distribution
and by anti-CD41 positivity.
Reticulated platelets (RP) were identiﬁed by the thiazole
orange method [30]: 10μl of PRP was incubated with
390μl of thiazole orange (Retic-Count; BD Biosciences) or
PBS as control and anti-CD41 at room temperature for
10 minutes, in the dark.
Immediately after incubation, samples were analysed by
ﬂow cytometry collecting 10000 CD41-positive events; the
percentage of RP was recorded, and the absolute number of
RP was calculated by multiplying by the platelet count.
2.8. Megakaryocyte Analyses. For single-cell suspensions
from bone marrow, BM was ﬂushed in PBS (Ca2+- and Mg2+-
free) containing 3% BSA, 5.5mM D-glucose, 10.2mM
trisodium citrate, and 10μM PGE1 were ﬁltered through a
sterile nylon mesh (70μm) and centrifuged (5min, 200g).
Cells were ﬁrst resuspended in FACS Lysing solution to
lyse red blood cells, then washed and resuspended in
PBS plus 2% FBS, and stained for 20 minutes on ice with
PE-conjugated CD41 (BD Biosciences, Cat. 558040) and
FITC-conjugated CD61 (BD Biosciences, Cat. 561911)
or FITC-conjugated CD42d (Emfret Analytics, Cat.
M061-1). The percentage of CD41-positive (CD41+) and
CD61-positive (CD61+) cells or of CD41-positive (CD41+)
and CD42d-positive (CD42d+) cells was evaluated by FACS
on a FITC gate, and PE was set at 1% on samples stained
with the control antibody [30]. CD41+/CD61+ was used as
marker of total megakaryocyte, and CD41+/CD42d+ as
marker of mature megakaryocytes.
For ROS detection, single-cell suspensions from bone
marrow were stained with PE-conjugated CD41 and incu-
bated with 20μM H2DCF-DA (2′,7′-dichlorodihydroﬂuor-
escein diacetate, Sigma-Aldrich) for 15 minutes at 37°C and
5% CO2, then samples were analysed by FACS. Live events
were collected on the basis of side scatter plots. MKs were
gated by identiﬁcation of CD41-PE-positive cells [31].
Flow cytometry was performed on a ﬂow FACS
“Novocyte 3000,” collecting 3000 events per sample.
2.9. Bone Marrow Histology. Immunohistochemistry was
performed on BM as previously described [30]. Tissues were
ﬁxed overnight in 4% formalin, embedded in paraﬃn, cut at
3μm, and mounted on polarized slides. BM samples were
decalciﬁed in 10% EDTA, pH8 for 10 days before paraﬃn
embedding. Sections were stained in Hematoxylin and Eosin
(H&E). Slides were dewaxed, rehydrated, washed in PBS
containing 0.1% Triton X100 for 15 minutes, and treated
with 3% H2O2 for 10 minutes to block endogenous peroxi-
dase. Antigen retrieval was performed with 0.01M citrate
buﬀer (pH6) in a water bath at 98°C for 10 or 30minutes
according to the antibody used. Slides were incubated
overnight at 4°C with the following primary antibodies:
anti-NOX1 polyclonal antibody (1 : 200, GeneTex, Cat.
GTX103888) or with rabbit preimmune IgGs (Vector
Laboratories, Cat. I-1000) as negative controls. For immu-
noperoxidase, biotinylated anti-rabbit secondary antibody
(Dako, Glostrup, Denmark, Cat. E0432) and then streptavi-
din/HRP (Dako, Glostrup, Denmark, Cat. P0397) were used
and developed with the DAB substrate kit (Sigma-Aldrich).
Slides were lightly counterstained with hematoxylin and
observed and digitalized by a Zeiss Axioskop (Carl Zeiss)
equipped with an intensiﬁed charge-coupled device (CCD)
camera system (Photometrics). The number and area of
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megakaryocytes were evaluated in hematoxylin and eosin
stained sections by counting 5–7 40x microscopic ﬁelds for
each tissue sample [32].
2.10. Statistical Analysis. Statistical analyses were per-
formed with GraphPad Prism 6.0 and SAS versus 9.4
software (SASA Institute). Data were analyzed by one-
or 2-way ANOVA with repeated measures for main
eﬀects of treatment and time or stimuli, followed by a Dunn’s
test or a Bonferroni post hoc analysis as appropriate. Values
of p < 0 05 were considered statistically signiﬁcant. Data are
expressed as mean± SEM. For each box-plot, the center line
illustrates the median, and box limits indicate the 25th and
75th percentiles.
3. Results
3.1. Eﬀect of Apocynin on Chronic Stress and Oxidative Stress.
To assess whether the chronic forced swimming treatment
for 4 days was suﬃcient to induce a stress-response, we
weighted adrenal glands as an index of terminal phase of
hypothalamic-pituitary-adrenal neuroendocrine system acti-
vation. As expected, adrenal gland weight was greater in
the stressed group of mice compared to the control group
(p < 0 05; Figure 2(a)). Apocynin treatment did not modify
the adrenal gland hypertrophy induced by forced swimming
stress (FSS; Figure 2(a)), suggesting that Apocynin does not
change the physiological response to the stress protocol. No
signiﬁcant diﬀerence in spleen or body weight between con-
trol and stressed mice with or without Apocynin treatment
was found (Figures 2(b) and 2(c)).
Next, we measured the plasma malondialdehyde
(P-MDA) levels, as marker of oxidative stress. The P-MDA
levels were higher in the FSS-group compared to the con-
trol (p < 0 01; Figure 2(d)). Interestingly, Apocynin admin-
istration restored the normal P-MDA levels in stressed
mice (Figure 2(d)).
3.2. Apocynin Prevented Arterial Thrombosis Induced by
Forced Swimming Stress (FSS). FSS accelerated occlusion
rates in FeCl3-injuried carotid arteries (Figure 3). In particu-
lar, FeCl3 application reduced dramatically the blood ﬂow
within 10 minutes and led to a stable occlusion in 100% of
mice exposed to FSS, but it was unable to induce a stable
occlusion in control mice within the same 30-minute obser-
vation period (Figure 3). In mice treated with Apocynin,
blood ﬂow was slightly but signiﬁcantly reduced in the ﬁrst
10 minutes after topical application of FeCl3 and remained
constant over all the observation period (Figure 3). The total
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Figure 2: Forced swimming treatment for 4 days was suﬃcient to increase oxidative stress. Weight of (a) adrenal gland, (b) spleen, and
(c) body and (d) plasma malondialdehyde (P-MDA) levels, from control mice (treated with vehicle) and from mice exposed to forced
swimming stress with vehicle (FSS) or with Apocynin (FSS +Apocynin). n = 12 mice/group. ∗p < 0 05, ∗∗p < 0 01, and ns: nonsigniﬁcant.
For each box-plot, the center line illustrates the median and box limits indicate the 25th and 75th percentiles. Data were analyzed by
the Kruskal-Willis test followed by a Dunn’s multiple comparison test.
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Figure 3: The propensity to arterial thrombosis induced by chronic stress is prevented by Apocynin treatment. (a) Blood ﬂow in the
carotid arteries of control mice (treated with vehicle) and from mice exposed to forced swimming stress with vehicle (FSS) or with
Apocynin (FSS +Apocynin) expressed relative to the value before injury. Data shown are mean± SEM and analyzed by 2-way ANOVA
with repeated measures for main eﬀects of treatment and time, followed by a Bonferroni post hoc analysis. (b) Time to thrombotic
occlusion mice; horizontal bars indicate the mean value for each group. n = 6 mice/group. ∗∗∗p < 0 005. Data were analyzed by the
Kruskal-Willis test followed by a Dunn’s multiple comparison test.
Control FSS FSS +
Apocynin
Le
uc
ko
cy
te
s 1
06
/휇
l
0
10
20
30
40
⁎⁎ ⁎⁎
(a)
Control FSS FSS +
Apocynin
Pl
at
el
et
s 1
04
/휇
l
0
50
100
150
200
⁎⁎ ⁎⁎⁎
(b)
Control FSS FSS +
Apocynin
FS
CH
-M
I
35
40
45
50
55
⁎⁎ ⁎⁎⁎
(c)
%
 o
f r
et
ic
ul
at
ed
 p
la
te
le
ts
Control FSS FSS +
Apocynin
0
5
10
15
20 ⁎⁎⁎⁎⁎⁎
(d)
Figure 4: Modiﬁcations of circulating cells induced by chronic stressed are reduced by Apocynin treatment. Numbers of circulating
(a) leukocytes and (b) platelets were counted, and (c) platelet size and (d) percentage of reticulated platelets were analysed by ﬂow
cytometry in control mice exposed to forced swimming stress (FSS) and treatment with or without Apocynin (FSS +Apocynin). n = 10
mice/group. ∗∗p < 0 01, ∗∗∗p < 0 005, and ∗∗∗∗p > 0 001. For each box-plot, the center line illustrates the median and box limits indicate
the 25th and 75th percentiles. Data were analyzed by the Kruskal-Willis test followed by a Dunn’s multiple comparison test.
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occlusion of carotid artery induced by FSS was completely
prevented in all treated mice (Figure 3).
No signiﬁcant diﬀerence in terms of basal levels of
blood ﬂow was noted between the animal groups (control:
0.616± 0.07ml/min; FSS: 0.557± 0.10ml/min and FSS+
Apocynin: 0.543± 0.08ml/min).
3.3. Eﬀect of Forced Swimming Stress (FSS) on Blood
Hemostasis. Thromboelastography analysis (ROTEM analy-
ses) in whole blood provided evidence that FSS aﬀected
blood hemostasis by shortening the clotting formation time
(CFT: control: 160.2± 10.39 sec and FSS: 90.67± 9.90 sec,
p < 0 005) and increasing the maximum clot ﬁrmness
(MCF: control: 60.33± 1.76mm and FSS: 67.83± 1.6mm,
p < 0 05) and maximum clot elasticity (MCE: control:
154.5± 11.73mm and FSS: 214.8± 16.27mm, p < 0 05). In
contrast, similar coagulation time in na-tem test (CT: con-
trol: 293.7± 15.38 sec and FSS: 235.3± 25.19 sec, p = 0 087)
and comparable MCF in ﬁb-tem test (MCF: control:
20.67± 1.91mm and FSS: 23.50± 2.62mm, p = 0 617) were
detected in control and FSS groups.
These data suggest that chronic stress did not aﬀect
coagulation pathway and ﬁbrinogen but instead, it promoted
hyperactivation of platelets.
3.4. Eﬀect of Apocynin on Circulating Cell Number and
Platelet Function in Response to Forced Swimming Stress
(FSS). As previously shown in mouse and human studies
[33–35], FSS increased the number of circulating leukocytes
(Figure 4(a), p < 0 01) and platelets (Figure 4(b), p < 0 01)
and enhanced platelet size (Figure 4(c), p < 0 01) and the
percentage of reticulated platelets (Figure 4(d), p < 0 001).
Apocynin reverted these changes in stressed mice toward
the restoration of the physiological number of leukocyte
and platelet shape (Figure 4).
Interestingly, activation of integrin αIIbβ3 (GPIIbIIIa)
(Figure 5(a), p < 0 05) as well as the expression of P-selectin
on platelet surface (Figure 5(b), p < 0 05) in response to
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Figure 5: Apocynin decreases platelet activation induced by chronic stress. Flow cytometry analyses of (a) GPIIbIIIa activation (JON/A-PE
antibody) and (b) P-selectin expression in washed platelets, and percentage of (c) platelet/monocyte, (d) platelet/neuthrophil, and (e) platelet/
lymphocyte aggregates in whole blood of control mice (treated with vehicle) and of mice exposed to forced swimming stress with vehicle (FSS)
or with Apocynin (FSS +Apocynin). n = 6 mice/group. ∗p < 0 05, ∗∗p < 0 01, ∗∗∗p < 0 005, and ∗∗∗∗p < 0 001. For each box-plot, the center
line illustrates the median and box limits indicate the 25th and 75th percentiles. Data were analyzed by 2-way ANOVA with repeated
measures for main eﬀects of treatment and stimuli, followed by a Bonferroni post hoc analysis.
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Figure 6: Continued.
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diﬀerent stimulus was higher in stressed mice compared to
control. The greater expression of P-selectin went hand in
hand with the enhanced percentage of platelet monocyte
(Figure 5(c), p < 0 001), platelet/neutrophil (Figure 5(d),
p < 0 001), or platelet/lymphocyte (Figure 5(e), p < 0 001)
aggregates in response to ADP.
Remarkably, the platelet hyperreactivity induced by FSS
was completely prevented by Apocynin treatment (Figure 5).
3.5. Eﬀect of Apocynin on Megakaryopoiesis in Stressed Mice.
To assess whether the thrombocytosis consequent to FSS
exposure was associated to the abnormal megakaryopoiesis,
bone marrow megakaryocytes were analyzed.
Histopathological analysis of bone marrow section
(Figure 6(a)) revealed a higher number of megakaryocytes
(MKs) in stressed mice compared to control (FSS: 11.04±
0.28 MKs/ﬁeld versus control: 7.93± 0.58 MKs/ﬁeld, p <
0 01; Figure 6(b)), and ﬂow cytometer analyses showed that
FSS increased signiﬁcantly the percentage of CD41+/CD61+
cells in bone marrow (Figure 6(c), p < 0 01). In addition,
careful analyses of these sections revealed that megakaryo-
cytes from stressed mice were larger (Figure 6(d), p < 0 005)
and displayed greater nuclear complexity (Figure 6(e)) com-
pared to control. In particular, higher percentage of polylo-
bulated megakaryocytes (p < 0 001) and lower percentage of
mononucleated (p < 0 01) or binucleated (p < 0 05) megakar-
yocytes were detected in bone marrow from stressed mice.
The advanced maturation state of megakaryocytes from
stressed mice suggested by morphological examination was
sustained by the enhanced expression of lineage diﬀerentia-
tion marker CD42d (Figure 6(f), p < 0 01). Interestingly,
Apocynin decreased markedly the number of megakaryo-
cytes (p < 0 01), but only slightly reduced the total area,
without aﬀecting their maturation state.
Finally, we showed that FSS decreased the NADPH/
NADP+ ratio (Figure 7(a)) and upregulated NOX1 expression
in bone marrow, including megakaryocytes (Figure 7(b)).
Interestingly, NOX1 is the most abundant NOX isoform in
this type of cells [36]. In addition, FSS speciﬁcally induced
reactive oxygen species (ROS) production in megakaryo-
cytes (Figure 7(c), p < 0 01). As expected, Apocynin restored
the physiological NADPH/NADP+ ratio and markedly
decreased ROS generation and NOX1 expression induced
by FSS (Figure 7).
4. Discussion
In this study, we show that Apocynin treatment, by
preventing ROS generation, restores the physiological mega-
karyopoiesis and platelet function and reduces arterial
thrombosis. Overall, these ﬁndings suggest that ROS play a
key role in the susceptibility to thrombosis induced by
chronic psychological/behavioral stress, aﬀecting the produc-
tion/activation of megakaryocytes, with consequent increase
of both number and reactivity of circulating platelets.
Chronic environmental/psychological stress increases
the hypothalamic-pituitary-adrenal axis activation [37]
and induces a dysregulation in norepinephrine system that
turns a homeostatic stress response into a pathological stress
response [38]. Then, the observation that chronic environ-
mental stress accelerates norepinephrine-mediated hemato-
poiesis promoting atherosclerotic plaque features associated
with vulnerable lesions [35] well explained the correlation
between psychological stress and acute myocardial infarction
emerged from the INTERHEART study [39]. However,
chronic environmental stress increases the risk for cardiovas-
cular disease also promoting a prothrombotic state [40–42].
As a matter of fact, chronic stress increases the levels of tissue
factor and of the plasminogen activation inhibitor-1 [40–42]
and the number of circulating platelets [33]. Interestingly,
here, we showed that 5 minutes of “forced swimming stress”
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Figure 6: Apocynin partially reduces megakaryocyte alteration induced by chronic stress. (a) Hematoxylin and Eosine (H&E) staining
of bone marrow from control mice (treated with vehicle) and from mice exposed to forced swimming stress with vehicle (FSS) or
with Apocynin (FSS +Apocynin). Circle indicates MKs. (b) Quantiﬁcation of panel (a) expressed as megakaryocytes per ﬁled (40x
magniﬁcation). Flow cytometric analyses: (c) percentage of CD41+/CD61+ cells and (f) percentage of CD41+/CD42d+ cells in bone
marrow of mice. Analysis of (d) area and of (e) nuclear complexity in megakaryocytes from control, stress, and stress +Apocynin mice.
n = 6 mice/group. ∗∗p < 0 01, ∗∗∗p < 0 005, and ns = nonsigniﬁcant. For each box-plot, the center line illustrates the median and box
limits indicate the 25th and 75th percentiles. Data were analyzed by the Kruskal-Willis test followed by a Dunn’s multiple comparison test.
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session, performed twice a day for 4 consecutive days, is
suﬃcient to induce a greater and more stable clot and to
predispose mice to arterial thrombosis, without aﬀecting
ﬁbrinogen and coagulation factor activation in agreement
with data obtained by other stress models, such as restraint
or foot shock stress [40, 43]. In addition, stressed mice not
only have a higher number of circulating cells (leukocytes
and platelets) but also have bigger, reticulated, and hyperre-
sponsive platelets as previously reported in human studies
[35, 44–46], which suggest modiﬁcation in bone marrow
milieu. Indeed, thrombopoiesis is a complex process result-
ing from many consecutive steps including proliferation
and maturation of megakaryocytes [47]. Accordingly, we
provide evidence that chronic stress increases the number
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Figure 7: Apocynin prevents oxidative stress in megakaryocytes of stressed mice. Control mice and mice exposed to forced swimming
stress (FSS) were treated with vehicle or with Apocynin (FSS +Apocynin), and then (a) NADPH/NADP+ ratio was measured in bonemarrow.
(b) Immunoperoxidase staining of NOX1 was performed in bone marrow. (c) Reactive oxygen species (ROS) levels were detected by H2DCF-
DA inMKs, as described in Methods. n = 6mice/group. ∗∗p < 0 01 and ∗∗∗∗p < 0 001. For each box-plot, the center line illustrates the median
and box limits indicate the 25th and 75th percentiles. Data were analyzed by the Kruskal-Willis test followed by a Dunn’s multiple
comparison test.
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of bone marrow megakaryocytes and it aﬀects morphology
as well. Megakaryocytes from stressed mice display an
advanced maturation state, in terms of bigger size, greater
nuclear complexity, and enhanced expression of CD42d
antigen. In addition, megakaryocytes from stressed mice
produce higher levels of ROS.
Previous studies have shown that both sympathetic
transmitters (e.g., norepinephrine and epinephrine) and
ROS promote proliferation of hematopoietic stem cells,
their diﬀerentiation to megakaryocytes, and they induce
megakaryocyte adhesion, migration, and proplatelet forma-
tion [33, 48]. Intriguingly, chronic stress increases norepi-
nephrine levels in bone marrow [35], which in turn
increases NADPH oxidase-derived superoxide in diﬀerent
type of cells [49, 50], suggesting a potential link between
these cellular messengers under chronic stress condition.
Moreover, we show that the NOX1 catalytic subunit,
expressed in diﬀerent type of cells, including macrophages,
hematopoietic stem cells, and megakaryocytes [36, 51, 52],
is upregulated by chronic stress in all bone marrow cells
and not only in megakaryocytes.
Interestingly, previous experiments performed with dif-
ferent oxidase inhibitors suggest that the NADPH oxidase
enzyme is the critical source of ROS in megakaryocytes [53]
and that NADPH oxidase inhibition completely prevents
the signaling cascade activation required for megakaryocyte
diﬀerentiations [54], reducing their polyploidization [36].
However, the single deletion of NOX1 or of NOX2 alone,
some of the subunits of NADPH oxidase, is not suﬃcient to
modulate MK polyploidization [36] as provided by in vivo
experiment, supporting the concept of a mutual compensa-
tion between the NOX isoforms.
Experimental and clinical data show that NADPH
oxidase plays a key role also in platelet ROS generation and
platelet activation [7, 55–57].
In line with these ﬁndings, we show here for the ﬁrst time
that Apocynin treatment prevents the detrimental eﬀect of
chronic psychological/behavioral stress, aﬀecting production
of ROS and leading to thrombosis, throughout the regulation
of megakaryopoiesis and platelet activation.
In particular, the strong eﬀect of Apocynin in the preven-
tion of prothrombotic phenotype promoted by environmen-
tal stress may be the result of a pleiotropic eﬀect of this
compound on diﬀerent cells and tissues (e.g., megakaryo-
cytes, bone marrow milieu, platelets, and vessel walls).
Indeed, the higher levels of NOX1 expression induced by
chronic stress in bone marrow cells, including also megakar-
yocytes, are signiﬁcantly reduced by Apocynin treatment. In
addition, Apocynin prevents platelet activation and improves
endothelial/vascular function [58, 59] reducing ROS by
preventing their generation by the binding of NOXO1 and
p47phox to p22phox and/or decreasing Rho kinases activity
[60] and acting as radical scavenger [18]. However, Apocynin
may aﬀect platelet function also by a mechanism diﬀerent
from the abovementioned, which has not been well identiﬁed
[61]. In particular, it is demonstrated that Apocynin might
indirectly inhibit NADPH oxidase activity depleting its
catalytic substrates such as NADPH [62] and decreasing
the intracellular reduce/oxidase GSH/GSSG ratio [63].
5. Conclusion
Our data not only provide new important knowledge
about the mechanisms by which chronic stress aﬀects
arterial thrombosis but also suggest that Apocynin is use-
ful in the prevention of thrombosis associated to chronic
environmental stress.
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